Press Releases Print Email
All Releases
View Summary VIVUS, Inc. Announces Intent to Reacquire U.S. and Canadian Rights for Stendra(R) (Avanafil)
Dec 31, 2015
PDF 14.0 KB Add to Briefcase
View Summary A New Take On New Year's And Chronic Weight Management: Smart Changes™ Program Combines Positive Lifestyle Changes With Prescription Medication For Weight Loss
Dec 29, 2015
PDF 20.6 KB Add to Briefcase
View Summary VIVUS Reports Third Quarter 2015 Financial Results
Nov 4, 2015
PDF 33.3 KB Add to Briefcase
View Summary VIVUS Announces Qsymia Presentations at Obesity Week 2015
Nov 3, 2015
PDF 46.9 KB Add to Briefcase
View Summary VIVUS Announces Date of Third Quarter 2015 Update and Financial Results Teleconference
Oct 28, 2015
PDF 9.8 KB Add to Briefcase
View Summary VIVUS, Inc. Board of Directors Expresses No Opinion and Remains Neutral Toward Icahn Group's Unsolicited Offer to Purchase 4.50% Convertible Senior Notes
Sep 22, 2015
PDF 9.5 KB Add to Briefcase
View Summary VIVUS Reports Second Quarter 2015 Financial Results
Jul 30, 2015
PDF 32.9 KB Add to Briefcase
View Summary VIVUS Announces Date of Second Quarter 2015 Update and Financial Results Conference Call
Jul 23, 2015
PDF 18.6 KB Add to Briefcase
View Summary VIVUS Announces Scientific Presentations
May 14, 2015
PDF 11.9 KB Add to Briefcase
View Summary VIVUS Reports First Quarter 2015 Financial Results
May 5, 2015
PDF 30.6 KB Add to Briefcase
View Summary VIVUS Announces Date of First Quarter 2015 Update and Financial Results Conference Call
Apr 30, 2015
PDF 9.3 KB Add to Briefcase
View Summary VIVUS Announces New Discount Program Through Sam's Club for Qsymia Patients
Apr 28, 2015
PDF 11.5 KB Add to Briefcase
View Summary VIVUS Announces Issuance of Two Additional U.S. Patents for Qsymia
Apr 21, 2015
PDF 12.3 KB Add to Briefcase
View Summary VIVUS Files Lawsuit Against Teva for Infringement of Qsymia Patents
Apr 15, 2015
PDF 11.9 KB Add to Briefcase
View Summary VIVUS to Present at Upcoming Investor Conference
Apr 10, 2015
PDF 9.4 KB Add to Briefcase
View Summary VIVUS Announces Operational Update
Mar 30, 2015
PDF 18.1 KB Add to Briefcase
View Summary VIVUS Reports Fourth Quarter and Year-End 2014 Financial Results
Feb 24, 2015
PDF 33.7 KB Add to Briefcase
View Summary VIVUS to Present at Upcoming Investor Conference
Feb 20, 2015
PDF 9.4 KB Add to Briefcase
View Summary VIVUS Announces Date of Fourth Quarter and Year End 2014 Update and Financial Results Conference Call
Feb 19, 2015
PDF 18.2 KB Add to Briefcase
View Summary VIVUS Announces European Approval of SPEDRA Label Amendment; SPEDRA Now First and Only Oral Erectile Dysfunction Treatment Approved in Europe to Be Taken Approximately 15 Minutes Before Sexual Activity
Jan 29, 2015
PDF 14.1 KB Add to Briefcase
Showing 1-20 of 405 Page: 1 2 3 ... 21  Next 20
= add release to Briefcase